connexin 47 Activators

Connexin 47 Activators encompasses a diverse range of compounds that can influence the activity of Connexin 47 (GJC2), a gap junction protein integral to the formation of gap junction channels in the central nervous system. These activators, while varied in their primary mechanisms of action, can modulate the function and dynamics of Connexin 47 by targeting pathways or processes associated with gap junction biology.

Among the notable members of this class are Retinoic Acid and Forskolin. Retinoic acid can modulate the expression of various connexins, thereby influencing Connexin 47 activity. Forskolin, on the other hand, raises intracellular cAMP levels, which can enhance gap junction communication, affecting Connexin 47. Epidermal Growth Factor (EGF) and TPA (12-O-Tetradecanoylphorbol-13-acetate) are other significant members that can influence gap junction intercellular communication by modulating connexin expression and function. Caffeine, known for its diverse cellular effects, can also modulate gap junction intercellular communication, thereby influencing Connexin 47 activity. Heptanol, while primarily blocking gap junction communication, can lead to a rebound activation of channels, including Connexin 47, upon its removal. Other compounds like Quinine, Gap27, Carbenoxolone, Mefloquine, Dibutyryl cAMP, and Gap26 have been identified to modulate gap junction communication, thereby potentially influencing Connexin 47 activity.